-
Dec 16, 2020, 14:15 PM
by
Full story
-
Dec 16, 2020, 14:15 PM
by
Full story
-
Dec 16, 2020, 14:15 PM
by
Specialist development pharmaceutical company AMZELL B.V has concluded discussions with the FDA ahead of initiating a Phase 3 trial of its new treatment for infantile epileptic disease, AMZ002.
Full story
-
Dec 16, 2020, 14:15 PM
by
Full story
-
Dec 16, 2020, 14:15 PM
by
Roambee’s technology solution for real-time logistics visibility has been proven to overcome many of the challenges of global COVID-19 vaccine distribution.
Full story
-
Dec 16, 2020, 14:15 PM
by
Tribal Health will bridge the gap between brand promise and brand experience in healthcare for clients GSK, Gilead and Medela.
Full story
-
Dec 16, 2020, 14:15 PM
by
Full story
-
Dec 16, 2020, 14:13 PM
by
VERICHEM LABORATORIES now offers the TRU-ZERO™ BILIRUBIN STANDARD – a liquid stable, protein based, standard material intended for the AMR and calibration verification of Total and Direct bilirubin assays with a number of chemistry testing systems.
Full story
-
Dec 16, 2020, 14:13 PM
by
Bailly Creat recently standardised on 530S peristaltic pumps from Watson-Marlow Fluid Technology Group for its lamination process.
Full story
-
Dec 16, 2020, 14:13 PM
by
Full story
-
Dec 16, 2020, 14:13 PM
by
Full story
-
Dec 16, 2020, 14:13 PM
by
CluePoints, the premier provider of Central Statistical Monitoring, Risk-Based Quality Management and Data Quality Oversight Software for clinical trials, today announced further expansion in Japan with the opening of a new office in Tokyo. Dedicated to serving their Japanese clients, the new office builds on CluePoints’ presence in the region, as demand for modern analytical software and services enabling proactive and exhaustive identification of clinical study quality issues continues to grow. The new location, along with a team located in Osaka, will strengthen CluePoints’ growing reputation within Japan and bring it closer to its Asia-Pacific region customers.
Full story
-
Dec 16, 2020, 14:12 PM
by
NanoSyrinx announces the appointment of Dr Jane Dancer to its Board as Non-Executive Director. Dr Dancer has over 30 years’ experience in business development across biotech, pharma and agrochemicals and her experience will help to drive NanoSyrinx’s ongoing fundraising activities and ambitious growth plans.
Full story
-
Dec 16, 2020, 14:12 PM
by
THREAD, an innovative technology and service provider that enables decentralized clinical research, joins a formidable alliance of 50 life sciences and healthcare organizations to accelerate the broad adoption of patient-focused decentralized clinical trials and research.
Full story
-
Dec 16, 2020, 14:12 PM
by
Student placement to provide invaluable commercial insight and hands-on experience.
The educational programme now in its fifth year
Full story
-
Dec 16, 2020, 14:12 PM
by
Resolve Biosciences today announced the completion of a $24 million Series A financing round and the appointment of Co-founder Jason T. Gammack as CEO
Full story
-
Dec 16, 2020, 14:12 PM
by
Scottish kidney specialist named winner at Scottish Health Awards for crucial work during coronavirus outbreak.
Full story
-
Dec 16, 2020, 14:11 PM
by
Full story
-
Dec 16, 2020, 14:11 PM
by
Full story
-
Dec 16, 2020, 14:11 PM
by
Full story